SRTA

Strata Critical Medical Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth 8/10
  • Momentum 5/10
Strata Critical Medical sales and earnings growth
SRTA Growth
Good
  • Revenue Y/Y 12.69%
  • EPS Y/Y 170.00%
  • FCF Y/Y -48.74%
Strata Critical Medical gross and profit margin trends
SRTA Profitability
Good
  • Gross margin 23.60%
  • EPS margin 17.70%
  • ROIC 26.00%
Strata Critical Medical net debt vs free cash flow
SRTA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Strata Critical Medical stock volatility is higher than the overall market. We give it a Great risk rating.

More Airports & Air Services stocks ↗